Genetic prevalence of antifungal resistance gene in cancer patients with Oropharyngeal Candidiasis from Iraq.
DOI:
https://doi.org/10.21123/bsj.2024.9415Keywords:
Antibiotic susceptibility, Biofilm, Candida albicans, ERG11, virulence.Abstract
As the population of immunocompromised patients grew, yeast infections became more common. There has been a significant rate of morbidity and mortality among patients with Candidiasis demonstrating increased resistance to antifungal medications. The main aim of this study was to determine the virulence gene of Candida albicans, evaluate antifungals used for Candidiasis, and biofilm formation, which is isolated from the mouth of individuals in the Baghdad Governorate From 1st October 2022 to 28th February 2023. This study included 120 oral swabs collected from people who had oral candidiasis, with an age group between10-65 including both Genders. The results obtained showed that the candidiasis frequency was more prevalent in males between the age group of 11-20 years. These results showed a statistically significant increase in the prevalence of ERG11 virulence gene among the biofilm-forming C. albicans fungus compared to other isolates with a significant difference (P = 0.863). Also, the study showed significant resistance of C. albicans to the antifungals fluconazole, itraconazole and fluconazole with the ability to form a biofilm. The present study also highlighted an elevated prevalence of the ERG11 gene in C. albicans and a strong association between the formation of biofilms and the presence of virulence gene was noted. Candidiasis is one of the fungal infections that are more prevalent among patients, and the virulence factor biofilm has an important role in increasing the pathogenicity of the fungus.
Received 12/09/2023
Revised 04/11/2023
Accepted 06/11/2023
Published Online First 20/05/2024
References
Tortorano AM, Prigitano A, Morroni G, Brescini L, Barchiesi F. Candidemia: evolution of drug resistance and novel therapeutic approaches. Infection and Drug Resistance. 2021 Dec 19:5543-53. https://doi.org/10.2147/IDR.S274872
Satish T Pote, Mahesh S Sonawane, Praveen Rahi, Sunil R Shah, Yogesh S Shouche, Milind S Patole, et al. Distribution of Pathogenic Yeasts in Different Clinical Samples: Their Identification, Antifungal Susceptibility Pattern, and Cell Invasion Assays. Infect Drug Resist. 2020; 13: 1133–45. https://doi.org/10.2147/IDR.S238002
Chakraborty M, Banu H, Gupta MK. Epidemiology and Antifungal Susceptibility of Candida Species causing Blood Stream Infections: An Eastern India Perspective. J Assoc Physicians India . 2021 Aug; 69(8): 11—12.
Boan P, Gardam D. Epidemiology and antifungal susceptibility patterns of candidemia from a tertiary centre in Western Australia. J Chemother . 2019; 31(3): 137–40. https://doi.org/10.1080/1120009X.2019.1595895
Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. Infections in Patients with Diabetes Mellitus. J Clin Med . 2019; 8(1). https://doi.org/10.3390/jcm8010076
Rodrigues AG. Yeast Engineering for New Antifungal Compounds: A Contextualized Overview. In: Hesham AE-L, Upadhyay RS, Sharma GD, Manoharachary C, Gupta VK, editors. Fungal Biotechnology and Bioengineering . Cham: Springer International Publishing; 2020. p. 17–36. https://doi.org/10.1007/978-3-030-41870-0_2
Sarsaiya S, Shi J, Chen J. Current Progress on Endophytic Microbial Dynamics on Dendrobium Plants BT - Fungal Biotechnology and Bioengineering. In: Hesham AE-L, Upadhyay RS, Sharma GD, Manoharachary C, Gupta VK, editors. Cham: Springer International Publishing; 2020. p. 397–418. https://doi.org/10.1007/978-3-030-41870-0_17
Damphousse CC, Miller N, Marrone DF. Experience-Dependent Egr1 Expression in the Hippocampus of Japanese Quail. Front Psychol . 2022; 13. https://doi.org/10.3389/fpsyg.2022.887790
Santos ALS dos. Aspartic Peptidase Inhibitors as Potential Bioactive Pharmacological Compounds Against Human Fungal Pathogens. In: Ahmad I, Owais M, Shahid M, Aqil F, editors. Combating Fungal Infections: Problems and Remedy . Berlin, Heidelberg: Springer Berlin Heidelberg; 2010. p. 289–325. https://doi.org/10.1007/978-3-642-12173-9_13
Lakshmy J, Katragadda R, Balaji J. Speciation and antifungal susceptibility of esophageal candidiasis in cancer patients in a tertiary care hospital in South India. J Med Allied Sci. 2016; 6: 29.
Abeed FK, Alrubayae IMN. Evaluation of virulence factors of clinical yeast isolates from nosocomial fungal infections with the determination of their antifungal susceptibility profile. Iran J Ichthyol. 2022; 9(Special Issue 1 (ABC)): 61–8.
Farmakiotis D, Kontoyiannis DP. Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management. Int J Antimicrob Agents . 2017; 50(3): 318–24. https://doi.org/10.1016/j.ijantimicag.2017.05.019
Amarasinghe AAPBN, Muhandiram MRS, Kodithuwakku SP, Thilakumara IP, Jayatilake JAMS. Identification, genotyping and invasive enzyme production of oral Candida species from denture induced stomatitis patients and healthy careers. J Oral Maxillofac Surgery, Med Pathol . 2021; 33(4): 467–74. https://doi.org/10.1016/j.ajoms.2021.02.004
Fonseca VJA, Braga AL, de Almeida RS, da Silva TG, da Silva JCP, de Lima LF, et al. Lectins ConA and ConM extracted from Canavalia ensiformis (L.) DC and Canavalia rosea (Sw.) DC inhibit planktonic Candida albicans and Candida tropicalis. Arch Microbiol . 2022; 204(6): 346. https://doi.org/10.1007/s00203-022-02959-x
Zottich U, de Oliveira IS, Fereira IG, Cerni FA, Karla de Castro Figueiredo B, Arantes EC, et al. Antifungal activity of Rhopalurus crassicauda venom against Candida spp. Toxicon X . 2022; 14: 100120. https://doi.org/10.1016/j.toxcx.2022.100120
Perlin DS. Antifungals: From Genomics to Resistance and the Development of Novel Agents. Clin Infect Dis. 2015 Oct 1; 61(7): 1213–4. https://doi.org/10.1093/cid/civ548
Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014; 10: 95–105. 18. Lattif AA K. Mukherjee P, Chandra J, Swindell K, Lockhart SR, Diekema DJ, et al. Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis. Int J Med Microbiol . 2010; 300(4): 265–70. https://doi.org/10.1016/j.ijmm.2009.09.001
Fiallos N de M, Ribeiro Aguiar AL, da Silva BN, Pergentino MLM, Rocha MFG, Sidrim JJC, et al. The Potential of Phenothiazines against Endodontic Pathogens: A Focus on Enterococcus-Candida Dual-Species Biofilm. Antibiotics. 2022; 11(11). https://doi.org/10.3390/antibiotics11111562
El-Ashmony MM, Raslan FS, Abdelhamid DH, Hafez HM, Abd El-Rahman OA. Potential Anti-fungal Activity of Lactobacilli Probiotic Against Fluconazole Resistant Candida albicans Clinical Isolates. Azhar Int J Pharm Med Sci . 2023; 3(1): 120–31. https://doi.org/10.21608/aijpms.2022.131769.1123
Abu-Mejdad N. Isolation and molecular identification of yeasts, study their potential for producing killer toxins and evaluation of toxins activity against some bacteria and pathogenic fungi. 2020 Feb. http://dx.doi.org/10.13140/RG.2.2.35900.59528
Dovo EE, Zohoncon TM, Tovo SF, Soubeiga ST, Kiendrebeogo IT, Yonli AT, et al. First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso. BMC Infect Dis. 2022; 22(1): 678. https://doi.org/10.1186/s12879-022-07619-5
Nouraei H, Jahromi MG, Jahromi LR, Zomorodian K, Pakshir K. Potential Pathogenicity of Candida Species Isolated from Oral Cavity of Patients with Diabetes Mellitus. Garg H, editor. Biomed Res Int . 2021; 2021: 9982744. https://doi.org/10.1155/2021/9982744
Castelo-Branco D de SCM, Paiva M de AN, Teixeira CEC, Caetano ÉP, Guedes GM de M, Cordeiro R de A, et al. Azole resistance in Candida from animals calls for the One Health approach to tackle the emergence of antimicrobial resistance. Med Mycol . 2020 Oct 1; 58(7): 896–905. https://doi.org/10.1093/mmy/myz135
Mohammadi F, Hemmat N, Bajalan Z, Javadi A. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal Candida albicans and Non-Candida albicans Species. Cantore S, editor. Biomed Res Int. 2021; 2021: 5598907. https://doi.org/10.1155/2021/5598907
Henry, K. W., Nickels, J. T., & Edlind, T. D. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother. 2000; 44(10),2693–2700. https://doi.org/10.1128/AAC.44.10.2693-2700.2000
Downloads
Issue
Section
License
Copyright (c) 2024 Muhamed Abd ulrahman Majeed , Abdulameer Jasim Mohammed , Omar Sadik Shalal
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
